Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 813.10
-20.00 (-2.40%)
Jun 1, 2026, 3:30 PM IST
Windlas Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 664.56 | 609.94 | 581.87 | 426.26 | 380.89 |
Depreciation & Amortization | 307.43 | 268.84 | 131.98 | 121.66 | 119.26 |
Other Amortization | - | 11.01 | 2.46 | 1.98 | 2.21 |
Loss (Gain) From Sale of Assets | - | -0.09 | -0.06 | -8.76 | -0.1 |
Asset Writedown & Restructuring Costs | - | - | - | 0.08 | - |
Loss (Gain) From Sale of Investments | -147.61 | -150.79 | -108.21 | -47.82 | -17.24 |
Stock-Based Compensation | 166.11 | 24.6 | 20.67 | 10.08 | 18.13 |
Provision & Write-off of Bad Debts | 8.93 | 1 | 27.49 | 22.75 | 3.48 |
Other Operating Activities | 86.22 | 8.28 | -6.13 | 20.22 | -39.65 |
Change in Accounts Receivable | -610.29 | -308.03 | -198.35 | -83.63 | -316.73 |
Change in Inventory | 195.6 | -191.95 | 125.49 | -160.28 | -172.49 |
Change in Accounts Payable | 606.54 | 357.26 | 437.68 | 245.12 | 233.04 |
Change in Other Net Operating Assets | -228.15 | 51.8 | 74.71 | 61.99 | -119.5 |
Operating Cash Flow | 1,049 | 681.87 | 1,090 | 609.65 | 91.3 |
Operating Cash Flow Growth | 53.89% | -37.42% | 78.72% | 567.74% | -20.29% |
Capital Expenditures | -676.64 | -521.94 | -376.84 | -708.9 | -148.04 |
Sale of Property, Plant & Equipment | - | 1.97 | 0.42 | 9.1 | 1.1 |
Investment in Securities | -254.51 | -236.94 | -561.67 | 513.2 | -1,424 |
Other Investing Activities | 13.24 | 16.27 | 17.41 | 45.5 | 25.62 |
Investing Cash Flow | -917.91 | -740.64 | -920.68 | -141.1 | -1,546 |
Short-Term Debt Issued | 27.58 | 270.08 | - | - | - |
Total Debt Issued | 27.58 | 270.08 | - | - | - |
Short-Term Debt Repaid | - | - | -2.26 | -53.42 | -248.07 |
Long-Term Debt Repaid | -28.52 | -145.44 | -16.33 | -16.52 | -9.05 |
Total Debt Repaid | -28.52 | -145.44 | -18.59 | -69.94 | -257.12 |
Net Debt Issued (Repaid) | -0.94 | 124.64 | -18.59 | -69.94 | -257.12 |
Issuance of Common Stock | 40.44 | - | - | - | 1,650 |
Repurchase of Common Stock | - | - | -40.23 | -271.93 | - |
Common Dividends Paid | -121.56 | -114.95 | -83.01 | -76.28 | - |
Other Financing Activities | -48.26 | 0.44 | -11.07 | -19.24 | -92 |
Financing Cash Flow | -130.32 | 10.13 | -152.9 | -437.39 | 1,301 |
Net Cash Flow | 1.11 | -48.64 | 16.02 | 31.16 | -153.6 |
Free Cash Flow | 372.7 | 159.93 | 712.76 | -99.25 | -56.74 |
Free Cash Flow Growth | 133.04% | -77.56% | - | - | - |
Free Cash Flow Margin | 4.12% | 2.10% | 11.30% | -1.93% | -1.22% |
Free Cash Flow Per Share | 17.47 | 7.57 | 34.15 | -4.59 | -2.77 |
Cash Interest Paid | 48.26 | 43.82 | 11.07 | 7.87 | 14.15 |
Cash Income Tax Paid | 151.52 | 208.84 | 186.48 | 97.16 | 88.8 |
Levered Free Cash Flow | 208.51 | 71.09 | 629.88 | -124.53 | -167.52 |
Unlevered Free Cash Flow | 238.67 | 98.48 | 636.79 | -119.6 | -158.67 |
Change in Working Capital | -36.3 | -90.92 | 439.53 | 63.2 | -375.68 |